KEGG   DRUG: Nogapendekin alfa inbakicept
Entry
D12888            Mixture   Drug                                   
Name
Nogapendekin alfa inbakicept;
Nogapendekin alfa inbakicept-pmln;
Anktiva (TN)
Product
ANKTIVA (Altor BioScience)
Component
Nogapendekin alfa [DR:D11821], Inbakicept [DR:D11747]
Remark
Product: D12888<US>
Efficacy
Antineoplastic, IL-15 receptor agonist
  Disease
Bladder cancer [DS:H00022]
Comment
Complex of Nogapendekin alfa [DR:D11821] and inbakicept [DR:D11747]
Target
IL15RA (CD215) [HSA:3601] [KO:K05074]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04672  Intestinal immune network for IgA production
hsa05200  Pathways in cancer
Brite
USP drug classification [BR:br08302]
 Antineoplastics
  Antineoplastics, Other
   Antineoplastics, Miscellaneous
    Nogapendekin Alfa Inbakicept
     D12888  Nogapendekin alfa inbakicept
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    IL15RA (CD215)
     D12888  Nogapendekin alfa inbakicept <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12888
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12888
Other DBs
PubChem: 497621301
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system